Neuropilin 2
Neuropilin 2 (NRP2) is a protein that in humans is encoded by the NRP2 gene.[5][6]
This gene encodes a member of the neuropilin family of receptor proteins. The encoded transmembrane protein binds to SEMA3C protein {sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C} and SEMA3F protein {sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F}, and interacts with vascular endothelial growth factor (VEGF). This protein may play a role in cardiovascular development, axon guidance, and tumorigenesis. Multiple transcript variants encoding distinct isoforms have been identified for this gene.[7]
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000118257 - Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000025969 - Ensembl, May 2017
- ↑ "Human PubMed Reference:".
- ↑ "Mouse PubMed Reference:".
- ↑ Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (Apr 1998). "Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor". Cell. 92 (6): 735–45. PMID 9529250. doi:10.1016/S0092-8674(00)81402-6.
- ↑ Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M (Nov 1997). "Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III". Neuron. 19 (3): 547–59. PMID 9331348. doi:10.1016/S0896-6273(00)80371-2.
- ↑ "Entrez Gene: NRP2 neuropilin 2".
Further reading
- Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999). "Vascular endothelial growth factor (VEGF) and its receptors.". FASEB J. 13 (1): 9–22. PMID 9872925.
- Kolodkin AL, Levengood DV, Rowe EG, et al. (1997). "Neuropilin is a semaphorin III receptor.". Cell. 90 (4): 753–62. PMID 9288754. doi:10.1016/S0092-8674(00)80535-8.
- Giger RJ, Urquhart ER, Gillespie SK, et al. (1999). "Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity.". Neuron. 21 (5): 1079–92. PMID 9856463. doi:10.1016/S0896-6273(00)80625-X.
- Chen H, He Z, Bagri A, Tessier-Lavigne M (1999). "Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins.". Neuron. 21 (6): 1283–90. PMID 9883722. doi:10.1016/S0896-6273(00)80648-0.
- Takahashi T, Nakamura F, Jin Z, et al. (1999). "Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors.". Nat. Neurosci. 1 (6): 487–93. PMID 10196546. doi:10.1038/2203.
- Rossignol M, Beggs AH, Pierce EA, Klagsbrun M (1999). "Human neuropilin-1 and neuropilin-2 map to 10p12 and 2q34, respectively.". Genomics. 57 (3): 459–60. PMID 10329017. doi:10.1006/geno.1999.5790.
- Tamagnone L, Artigiani S, Chen H, et al. (1999). "Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.". Cell. 99 (1): 71–80. PMID 10520995. doi:10.1016/S0092-8674(00)80063-X.
- Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G (2000). "Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected].". J. Biol. Chem. 275 (24): 18040–5. PMID 10748121. doi:10.1074/jbc.M909259199.
- Handa A, Tokunaga T, Tsuchida T, et al. (2000). "Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma.". Int. J. Oncol. 17 (2): 291–5. PMID 10891538. doi:10.3892/ijo.17.2.291.
- Rossignol M, Gagnon ML, Klagsbrun M (2001). "Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms.". Genomics. 70 (2): 211–22. PMID 11112349. doi:10.1006/geno.2000.6381.
- Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G (2001). "Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.". J. Biol. Chem. 276 (22): 18688–94. PMID 11278319. doi:10.1074/jbc.M006909200.
- Cohen T, Gluzman-Poltorak Z, Brodzky A, et al. (2001). "Neuroendocrine cells along the digestive tract express neuropilin-2.". Biochem. Biophys. Res. Commun. 284 (2): 395–403. PMID 11394892. doi:10.1006/bbrc.2001.4958.
- Herzog Y, Kalcheim C, Kahane N, et al. (2002). "Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins.". Mech. Dev. 109 (1): 115–9. PMID 11677062. doi:10.1016/S0925-4773(01)00518-4.
- Oh H, Takagi H, Otani A, et al. (2002). "Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.". Proc. Natl. Acad. Sci. U.S.A. 99 (1): 383–8. PMC 117569
. PMID 11756651. doi:10.1073/pnas.012074399. - Fakhari M, Pullirsch D, Abraham D, et al. (2002). "Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma.". Cancer. 94 (1): 258–63. PMID 11815985. doi:10.1002/cncr.10177.
- Cohen T, Herzog Y, Brodzky A, et al. (2002). "Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.". J. Pathol. 198 (1): 77–82. PMID 12210066. doi:10.1002/path.1179.
- Kawakami T, Tokunaga T, Hatanaka H, et al. (2003). "Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.". Cancer. 95 (10): 2196–201. PMID 12412174. doi:10.1002/cncr.10936.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. PMC 139241 . PMID 12477932. doi:10.1073/pnas.242603899.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.